For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...
More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.
Hosted on MSN
Children’s asthma attacks cut nearly in half with 2-in-1 inhaler according to new study
A new study led by the Medical Research Institute of New Zealand (MRINZ) has found that asthmatic children don't face any additional risk from using inhalers currently reserved for teens and adults.
Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...
Children and young adults had less access to meds if they lived in states where more people lost Medicaid coverage For example, children had reduced access to asthma inhalers MONDAY, May 12, 2025 ...
Children and adolescents with asthma who use inhalers may experience significantly more tooth wear, specifically on buccal and labial surfaces and in permanent teeth. The study was published on ...
Asthma causes inflammation and narrowing of the airways, making it harder to breathe. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath. These symptoms can vary in ...
A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the widely-used salbutamol inhaler. The corresponding study was published in The Lancet.
Children and young adults had less access to meds if they lived in states where more people lost Medicaid coverage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results